The collaboration will leverage DiaSorin's Liaion MDX PCR system, and Tecan's Fluent Laboratory Automation Solution to provide users a complete sample-to-result system.
The new algorithm, called TOPSPIN, complements the company's MMprofiler test. It is considering making TOPSPIN-generated data available to its MMprofiler patients.
The two firms are collaborating on a system to share genotypic, phenotypic, and treatment outcomes data with physicians on a mobile-device network.
The partners will work to develop and distribute IROA Technologies' kit for chemically labeling metabolites for mass spectrometry analysis.
The company is also developing a next-generation sequencing product that may be applied at the point of need to test for bloodstream infections and later as a liquid biopsy for cancer.
As part of the agreement, the organizations will develop a joint Seattle-Shenzhen Institute.
The tools the partners plan to develop will help researchers optimize genomic analysis workflows and better identify links between genes and disease.
The partners will develop a new product using MBio's multiplex, point-of-care testing system and Roka's experience in food safety testing.
The partners plan to develop a computational platform that automates pipelines and processes for biomarker discovery, drug recovery and repositioning, and more.
The companies will collaborate on a test to evaluate programmed death-ligand 1 protein expression levels in tumor tissue and its microenvironment.
Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.
Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.
China is embracing preimplantation genetic diagnosis, Nature News reports.
In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.